Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 170


The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury.

Barbier-Torres L, Iruzubieta P, Fernández-Ramos D, Delgado TC, Taibo D, Guitiérrez-de-Juan V, Varela-Rey M, Azkargorta M, Navasa N, Fernández-Tussy P, Zubiete-Franco I, Simon J, Lopitz-Otsoa F, Lachiondo-Ortega S, Crespo J, Masson S, McCain MV, Villa E, Reeves H, Elortza F, Lucena MI, Hernández-Alvarez MI, Zorzano A, Andrade RJ, Lu SC, Mato JM, Anguita J, Rincón M, Martínez-Chantar ML.

Nat Commun. 2017 Dec 12;8(1):2068. doi: 10.1038/s41467-017-01970-x.


NAFLD-which patients should have hepatocellular carcinoma surveillance?

Elcioglu ZC, Reeves HL.

Hepatobiliary Surg Nutr. 2017 Oct;6(5):353-355. doi: 10.21037/hbsn.2017.06.04. No abstract available.


Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?

Margetts J, Ogle LF, Chan SL, Chan AWH, Chan KCA, Jamieson D, Willoughby CE, Mann DA, Wilson CL, Manas DM, Yeo W, Reeves HL.

Br J Cancer. 2018 Jan;118(2):248-257. doi: 10.1038/bjc.2017.386. Epub 2017 Nov 9.


Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease.

Donati B, Pietrelli A, Pingitore P, Dongiovanni P, Caddeo A, Walker L, Baselli G, Pelusi S, Rosso C, Vanni E, Daly A, Mancina RM, Grieco A, Miele L, Grimaudo S, Craxi A, Petta S, De Luca L, Maier S, Soardo G, Bugianesi E, Colli F, Romagnoli R, Anstee QM, Reeves HL, Fracanzani AL, Fargion S, Romeo S, Valenti L.

Cancer Med. 2017 Aug;6(8):1930-1940. doi: 10.1002/cam4.1078. Epub 2017 Jul 4.


MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals.

Donati B, Dongiovanni P, Romeo S, Meroni M, McCain M, Miele L, Petta S, Maier S, Rosso C, De Luca L, Vanni E, Grimaudo S, Romagnoli R, Colli F, Ferri F, Mancina RM, Iruzubieta P, Craxi A, Fracanzani AL, Grieco A, Corradini SG, Aghemo A, Colombo M, Soardo G, Bugianesi E, Reeves H, Anstee QM, Fargion S, Valenti L.

Sci Rep. 2017 Jul 3;7(1):4492. doi: 10.1038/s41598-017-04991-0.


Opposite effects of a glucokinase activator and metformin on glucose-regulated gene expression in hepatocytes.

Al-Oanzi ZH, Fountana S, Moonira T, Tudhope SJ, Petrie JL, Alshawi A, Patman G, Arden C, Reeves HL, Agius L.

Diabetes Obes Metab. 2017 Aug;19(8):1078-1087. doi: 10.1111/dom.12910. Epub 2017 Apr 10.


Dynamic changes in absolute immature platelet count suggest the presence of a coexisting immune process in the setting of thrombotic thrombocytopenic purpura.

Stefaniuk CM, Reeves HM, Maitta RW.

Transfusion. 2017 Apr;57(4):913-918. doi: 10.1111/trf.13974. Epub 2017 Jan 12.


Unexpected Non-Maternally Derived Anti-PP1Pk in an 11-Week-Old Patient.

Reeves HM, Cary V, Mino MA, McGrath C, Westra JA, Piccone C, Downes KA.

J Pediatr. 2017 Feb;181:302-305. doi: 10.1016/j.jpeds.2016.10.042. Epub 2016 Nov 14.


Urinary Metabotyping of Hepatocellular Carcinoma in a UK Cohort Using Proton Nuclear Magnetic Resonance Spectroscopy.

Shariff MI, Kim JU, Ladep NG, Crossey MM, Koomson LK, Zabron A, Reeves H, Cramp M, Ryder S, Greer S, Cox IJ, Williams R, Holmes E, Nash K, Taylor-Robinson SD.

J Clin Exp Hepatol. 2016 Sep;6(3):186-194. Epub 2016 Apr 20.


Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease.

Than NN, Ghazanfar A, Hodson J, Tehami N, Coldham C, Mergental H, Manas D, Shah T, Newsome PN, Reeves H, Shetty S.

QJM. 2017 Feb 1;110(2):73-81. doi: 10.1093/qjmed/hcw151.


Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma.

Alhasan SF, Haugk B, Ogle LF, Beale GS, Long A, Burt AD, Tiniakos D, Televantou D, Coxon F, Newell DR, Charnley R, Reeves HL.

Br J Cancer. 2016 Sep 27;115(7):797-804. doi: 10.1038/bjc.2016.264. Epub 2016 Aug 25.


Comparison of two apheresis systems during hematopoietic progenitor stem cell collections at a tertiary medical center.

Li Y, Li J, Reeves HM, Reyes R, Maitta RW.

Transfusion. 2016 Nov;56(11):2833-2838. doi: 10.1111/trf.13754. Epub 2016 Aug 3.


Combination PARP and HDAC inhibition as a therapeutic strategy targeting liver cancer stem cells?

Willoughby CE, Reeves HL.

Chin Clin Oncol. 2016 Oct;5(5):60. doi: 10.21037/cco.2016.03.21. Epub 2016 Apr 12. No abstract available.


Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma?

Ogle LF, Orr JG, Willoughby CE, Hutton C, McPherson S, Plummer R, Boddy AV, Curtin NJ, Jamieson D, Reeves HL.

J Hepatol. 2016 Aug;65(2):305-13. doi: 10.1016/j.jhep.2016.04.014. Epub 2016 Apr 27.


Design and synthesis of biphenyl and biphenyl ether inhibitors of sulfatases.

Reuillon T, Alhasan SF, Beale GS, Bertoli A, Brennan A, Cano C, Reeves HL, Newell DR, Golding BT, Miller DC, Griffin RJ.

Chem Sci. 2016 Apr 21;7(4):2821-2826. doi: 10.1039/c5sc03612g. Epub 2016 Jan 11.


A national survey of the provision of ultrasound surveillance for the detection of hepatocellular carcinoma.

Cross TJS, Villaneuva A, Shetty S, Wilkes E, Collins P, Adair A, Jones RL, Foxton MR, Meyer T, Stern N, Warshow U, Khan N, Prince M, Khakoo S, Alexander GJ, Khan S, Reeves H, Marshall A, Williams R.

Frontline Gastroenterol. 2016 Apr;7(2):82-89. doi: 10.1136/flgastro-2015-100617. Epub 2015 Dec 7.


Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade.

Toyoda H, Lai PB, O'Beirne J, Chong CC, Berhane S, Reeves H, Manas D, Fox RP, Yeo W, Mo F, Chan AW, Tada T, Iñarrairaegui M, Vogel A, Schweitzer N, Chan SL, Sangro B, Kumada T, Johnson PJ.

Br J Cancer. 2016 Mar 29;114(7):744-50. doi: 10.1038/bjc.2016.33.


Imaging changes after breast reconstruction with fat grafting - Retrospective study of 90 breast cancer.

Noor L, Reeves HR, Kumar D, Alozairi O, Bhaskar P.

Pak J Med Sci. 2016 Jan-Feb;32(1):8-12. doi: 10.12669/pjms.321.9460.


Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD.

Reeves HL, Zaki MY, Day CP.

Dig Dis Sci. 2016 May;61(5):1234-45. doi: 10.1007/s10620-016-4085-6. Epub 2016 Feb 26. Review.


Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients.

Berhane S, Toyoda H, Tada T, Kumada T, Kagebayashi C, Satomura S, Schweitzer N, Vogel A, Manns MP, Benckert J, Berg T, Ebker M, Best J, Dechêne A, Gerken G, Schlaak JF, Weinmann A, Wörns MA, Galle P, Yeo W, Mo F, Chan SL, Reeves H, Cox T, Johnson P.

Clin Gastroenterol Hepatol. 2016 Jun;14(6):875-886.e6. doi: 10.1016/j.cgh.2015.12.042. Epub 2016 Jan 13.


Supplemental Content

Loading ...
Support Center